Stem cell blogs are an increasingly important part of the stem cell field. Today in 2013 it is a far different world for stem cell blogs than when I first had my idea to have a blog in 2009 and when I got it going in early 2010. It was pretty darn lonely back then. […]
Stem Cell Blog of the Year 2013: Signals Blog by Stem Cell Network/CCRM Read More »
The 2013 World Stem Cell Summit this past week in San Diego was an amazing experience with so many positives to it. Being the recipient of the National Advocacy Award for stem cells was certainly wonderful and exciting. The fact that Michael J. Fox was a past recipient of this same award blows my mind. To
What the National Advocacy Award for Stem Cells Means to Me Read More »
Scientific reviews and scores are in for CIRM’s Disease Team III RFA. We don’t know the identifies of the applicants yet, but 3 out of 4 of the top scoring grants recommended outright for funding are focused on cancer. As a cancer stem cell researcher (and cancer survivor) I’m excited to see how well these
Cancer Grants Perform Well With CIRM Disease Team Reviews Read More »
I recently did a poll asking readers of my blog to vote on the iPS cell paper of the year for 2013. The vote kind of seesawed at the beginning, but in the end with 100 votes cast the paper by the Hannah lab on near-perfect iPS cell production won out (see votes at left).
Hannah near-perfect reprogramming voted as iPS cell paper of 2013 Read More »
Where do things stand with some players in the for-profit world of stem cell and cellular medicine companies? Here are a few brief news items with quick analysis. Mesoblast is dominating the news of late. Mesoblast reported good news from its Phase II safety trial for its mesenchymal progenitor cell (MPC) product in patients with
Stem Cell & Cell Med Industry Briefs Read More »
I’m flying out to San Diego today for the World Stem Cell Summit. I’ve been attending this great meeting every year lately and I always return home feeling more informed and energized. Here’s this year’s agenda. At the meeting, I will be doing a book signing tomorrow, Wednesday December 4th, from noon-2pm near the WSCS
Heading to 2013 World Stem Cell Summit Read More »
I recently interviewed Drs. Elliot Lander and Mark Berman of the Cell Surgical Network. It’s an affiliated chain of clinics selling stem cell interventions for more than a dozen medical conditions. You can read Part 1 here and Part 2 here of the interview where we cover 10 important questions. Today is Part 3, where I explain why their answers
Cell Surgical Network Series Part 3: Key Concerns Read More »
The stem cell field has seen quite a few high-profile, intriguing papers on induced pluripotent stem (iPS) cells. Which do you think is the iPS cell paper of the year for 2013? The iPS cell field continues to advance rapidly. If you think one not listed is the best, let us know in the comments.
iPS cell paper of the year 2013: cast your vote Read More »
Today I am posting Part 2 of my interview with Drs. Lander and Berman of the Cell Surgical Network. You can read Part 1 here, which is an interesting look inside the Network. The final portion of this blog post series, Part 3, is my take on their answers and you might not be surprised that
Cell Surgical Network Interview Part 2: SVF, FDA, & Homologous Use Read More »
Yesterday I posted a list of a dozen potential candidates to be considered for the position of the new CIRM President. To be clear, that list is not my list. It is also not CIRM’s list and I’m sure that CIRM’s Search Committee has its own ideas of course. The list in yesterday’s post was
Some More Thoughts on the Search for a New CIRM President Read More »